Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-02-24 @ 1:01 AM
Study NCT ID:
NCT02352558
Status:
COMPLETED
Last Update Posted:
2023-11-14
First Post:
2015-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BBI608-103HEME
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None